Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Orientia tsutsugamushi | 2 | 2019 | 45 | 0.96 | Why? |
| Scrub Typhus | 2 | 2019 | 68 | 0.90 | Why? |
| Phosphines | 1 | 2018 | 6 | 0.79 | Why? |
| Aluminum Compounds | 1 | 2018 | 17 | 0.79 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 2 | 2018 | 800 | 0.77 | Why? |
| Dental Anxiety | 1 | 2017 | 17 | 0.73 | Why? |
| Mycobacterium avium | 1 | 2017 | 10 | 0.71 | Why? |
| Organophosphate Poisoning | 1 | 2016 | 2 | 0.69 | Why? |
| Fasciculation | 1 | 2016 | 5 | 0.68 | Why? |
| Erdheim-Chester Disease | 1 | 2017 | 50 | 0.67 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.63 | Why? |
| Leptin | 1 | 2017 | 141 | 0.62 | Why? |
| Drug Hypersensitivity Syndrome | 1 | 2017 | 74 | 0.61 | Why? |
| Insecticides | 1 | 2016 | 178 | 0.57 | Why? |
| Hemoptysis | 1 | 2017 | 172 | 0.56 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.56 | Why? |
| Cholecalciferol | 1 | 2018 | 246 | 0.55 | Why? |
| Enterovirus Infections | 1 | 2018 | 404 | 0.53 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.52 | Why? |
| Oral Health | 1 | 2017 | 401 | 0.50 | Why? |
| Patient Outcome Assessment | 1 | 2017 | 707 | 0.49 | Why? |
| Down Syndrome | 1 | 2017 | 397 | 0.48 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.42 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.37 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.35 | Why? |
| Tuberculosis, Pulmonary | 1 | 2017 | 1171 | 0.32 | Why? |
| Carbon Monoxide Poisoning | 1 | 2006 | 24 | 0.32 | Why? |
| India | 17 | 2021 | 11875 | 0.32 | Why? |
| Granulocyte Colony-Stimulating Factor | 2 | 2018 | 264 | 0.31 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.29 | Why? |
| Attitude to Health | 1 | 2017 | 2002 | 0.27 | Why? |
| Ascites | 2 | 2018 | 65 | 0.27 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.27 | Why? |
| Fatal Outcome | 3 | 2018 | 3438 | 0.26 | Why? |
| Vehicle Emissions | 1 | 2006 | 328 | 0.26 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2018 | 1969 | 0.25 | Why? |
| Tertiary Care Centers | 9 | 2021 | 8248 | 0.25 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.23 | Why? |
| Malaria, Falciparum | 1 | 2006 | 377 | 0.23 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.22 | Why? |
| Mass Drug Administration | 1 | 2021 | 143 | 0.20 | Why? |
| Dengue | 2 | 2018 | 1565 | 0.20 | Why? |
| Antidotes | 1 | 2019 | 46 | 0.20 | Why? |
| Liver Cirrhosis | 3 | 2018 | 1810 | 0.20 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.20 | Why? |
| Periodontitis | 1 | 2021 | 171 | 0.19 | Why? |
| Pyomyositis | 1 | 2018 | 12 | 0.19 | Why? |
| Hepatorenal Syndrome | 1 | 2018 | 26 | 0.18 | Why? |
| Hypopituitarism | 1 | 2018 | 64 | 0.18 | Why? |
| Tobacco Use Disorder | 1 | 2021 | 163 | 0.18 | Why? |
| Pituitary Gland | 1 | 2018 | 65 | 0.18 | Why? |
| Snake Bites | 1 | 2018 | 50 | 0.18 | Why? |
| Male | 38 | 2021 | 367725 | 0.17 | Why? |
| Liver Circulation | 1 | 2017 | 12 | 0.17 | Why? |
| Hepatitis, Alcoholic | 1 | 2018 | 61 | 0.17 | Why? |
| Free Radical Scavengers | 1 | 2018 | 82 | 0.17 | Why? |
| Methanol | 1 | 2019 | 149 | 0.17 | Why? |
| Myoglobin | 1 | 2018 | 143 | 0.17 | Why? |
| Plasmodium vivax | 1 | 2018 | 154 | 0.16 | Why? |
| Renal Circulation | 1 | 2017 | 44 | 0.16 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.16 | Why? |
| Human Growth Hormone | 1 | 2018 | 120 | 0.16 | Why? |
| Antimalarials | 2 | 2021 | 2505 | 0.16 | Why? |
| Malaria, Vivax | 1 | 2018 | 152 | 0.16 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.16 | Why? |
| Hypothyroidism | 1 | 2019 | 239 | 0.16 | Why? |
| Creatine Kinase, MB Form | 1 | 2018 | 259 | 0.16 | Why? |
| Body Height | 1 | 2016 | 100 | 0.16 | Why? |
| Dental Clinics | 1 | 2017 | 149 | 0.15 | Why? |
| Infant, Small for Gestational Age | 1 | 2016 | 151 | 0.15 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.15 | Why? |
| Cardiac Tamponade | 1 | 2019 | 165 | 0.15 | Why? |
| Cardiac Output | 1 | 2017 | 183 | 0.15 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.15 | Why? |
| Adrenal Insufficiency | 1 | 2018 | 190 | 0.15 | Why? |
| Peritonitis | 1 | 2017 | 217 | 0.15 | Why? |
| Dental Caries | 1 | 2017 | 163 | 0.14 | Why? |
| Female | 31 | 2021 | 380317 | 0.14 | Why? |
| Acetylcysteine | 1 | 2018 | 255 | 0.14 | Why? |
| Liver Failure | 1 | 2018 | 266 | 0.14 | Why? |
| Perfusion Imaging | 1 | 2017 | 199 | 0.14 | Why? |
| Insulin Resistance | 2 | 2017 | 669 | 0.14 | Why? |
| Kidney Failure, Chronic | 2 | 2021 | 3222 | 0.14 | Why? |
| Child | 9 | 2021 | 70012 | 0.14 | Why? |
| Fungi | 1 | 2017 | 471 | 0.13 | Why? |
| Hypoglycemia | 1 | 2018 | 406 | 0.13 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.13 | Why? |
| Adult | 28 | 2021 | 244371 | 0.13 | Why? |
| Ultrasonography, Doppler | 1 | 2017 | 406 | 0.13 | Why? |
| Humans | 49 | 2021 | 930598 | 0.13 | Why? |
| Alcoholism | 1 | 2021 | 691 | 0.12 | Why? |
| Young Adult | 17 | 2021 | 93724 | 0.12 | Why? |
| Spleen | 1 | 2017 | 877 | 0.12 | Why? |
| Bronchiectasis | 1 | 2017 | 312 | 0.12 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.12 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.12 | Why? |
| Child Development | 1 | 2016 | 352 | 0.12 | Why? |
| Microvessels | 1 | 2017 | 490 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.12 | Why? |
| Fluid Therapy | 1 | 2017 | 628 | 0.12 | Why? |
| Peritoneal Dialysis | 1 | 2017 | 498 | 0.11 | Why? |
| Smokers | 1 | 2017 | 550 | 0.11 | Why? |
| Behavior, Addictive | 1 | 2018 | 535 | 0.11 | Why? |
| Mucormycosis | 1 | 2021 | 832 | 0.11 | Why? |
| Child, Preschool | 4 | 2019 | 36283 | 0.11 | Why? |
| Kidney Transplantation | 2 | 2021 | 5397 | 0.11 | Why? |
| Medical Staff, Hospital | 1 | 2021 | 1258 | 0.10 | Why? |
| Body Weight | 1 | 2016 | 1074 | 0.10 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 526 | 0.10 | Why? |
| Personnel, Hospital | 2 | 2021 | 2273 | 0.10 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.10 | Why? |
| Suicide, Attempted | 1 | 2016 | 599 | 0.10 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.10 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.10 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.10 | Why? |
| Midodrine | 1 | 2008 | 7 | 0.10 | Why? |
| Paracentesis | 1 | 2008 | 25 | 0.09 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.09 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Psychiatry | 1 | 2020 | 1289 | 0.09 | Why? |
| Metabolic Syndrome | 1 | 2016 | 810 | 0.09 | Why? |
| Depressive Disorder | 1 | 2018 | 1236 | 0.09 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 9706 | 0.09 | Why? |
| Hypovolemia | 1 | 2008 | 65 | 0.09 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.09 | Why? |
| Echocardiography | 2 | 2019 | 3661 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Resilience, Psychological | 1 | 2021 | 2329 | 0.08 | Why? |
| Occupational Diseases | 1 | 2021 | 2787 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.07 | Why? |
| Organ Transplantation | 1 | 2020 | 2616 | 0.07 | Why? |
| Genetic Variation | 1 | 2019 | 3919 | 0.07 | Why? |
| Aged | 13 | 2021 | 215776 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Vasoconstrictor Agents | 1 | 2008 | 714 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2018 | 3388 | 0.06 | Why? |
| Cross-Sectional Studies | 4 | 2021 | 53120 | 0.06 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Survivors | 3 | 2021 | 2619 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Matrix Metalloproteinase 8 | 1 | 2021 | 45 | 0.06 | Why? |
| Rhizopus | 1 | 2021 | 32 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Internet | 1 | 2018 | 6204 | 0.05 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.05 | Why? |
| Contraindications, Drug | 1 | 2021 | 281 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.05 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Russell's Viper | 1 | 2018 | 2 | 0.05 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.05 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.05 | Why? |
| Preliminary Data | 1 | 2021 | 457 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.05 | Why? |
| Pericardiocentesis | 1 | 2019 | 84 | 0.05 | Why? |
| Emergency Service, Hospital | 3 | 2019 | 14232 | 0.05 | Why? |
| Multivariate Analysis | 2 | 2021 | 5440 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.05 | Why? |
| Sulfur Hexafluoride | 1 | 2017 | 15 | 0.04 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.04 | Why? |
| Internship and Residency | 1 | 2018 | 4987 | 0.04 | Why? |
| Blood | 1 | 2018 | 274 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.04 | Why? |
| Pentoxifylline | 1 | 2018 | 80 | 0.04 | Why? |
| Poisoning | 1 | 2019 | 176 | 0.04 | Why? |
| Alcoholic Beverages | 1 | 2019 | 186 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Pharyngitis | 1 | 2021 | 687 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Poverty Areas | 1 | 2021 | 556 | 0.04 | Why? |
| Electrocardiography | 2 | 2021 | 3957 | 0.04 | Why? |
| Semen | 1 | 2021 | 550 | 0.04 | Why? |
| Organizational Policy | 1 | 2021 | 694 | 0.04 | Why? |
| Edema | 1 | 2019 | 333 | 0.04 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Esophagus | 1 | 2017 | 139 | 0.04 | Why? |
| Patient Selection | 2 | 2021 | 4560 | 0.04 | Why? |
| Stress, Psychological | 1 | 2018 | 10231 | 0.04 | Why? |
| Phospholipids | 1 | 2017 | 202 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| Models, Organizational | 1 | 2021 | 908 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| Donor Selection | 1 | 2021 | 804 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.03 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2018 | 835 | 0.03 | Why? |
| Informed Consent | 1 | 2021 | 890 | 0.03 | Why? |
| Demography | 1 | 2021 | 1660 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Triglycerides | 1 | 2016 | 478 | 0.03 | Why? |
| Developing Countries | 2 | 2021 | 4283 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Cognition | 1 | 2021 | 1394 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Pharmacies | 1 | 2017 | 356 | 0.03 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.03 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.03 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.03 | Why? |
| Diagnosis, Differential | 1 | 2006 | 7220 | 0.03 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.03 | Why? |
| Long QT Syndrome | 1 | 2021 | 1047 | 0.03 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.03 | Why? |
| Liver Function Tests | 1 | 2018 | 1325 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Radiography | 1 | 2019 | 1576 | 0.03 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.03 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.03 | Why? |
| Troponin I | 1 | 2018 | 1298 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2019 | 88759 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.02 | Why? |
| Hospitals, University | 1 | 2021 | 4173 | 0.02 | Why? |
| Workplace | 1 | 2021 | 2075 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Hydrocortisone | 1 | 2018 | 1790 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Cough | 1 | 2021 | 4891 | 0.02 | Why? |
| Health Promotion | 1 | 2020 | 2020 | 0.02 | Why? |
| Personal Protective Equipment | 2 | 2021 | 15978 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Dyspnea | 1 | 2019 | 3847 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.02 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.02 | Why? |
| Serum Albumin | 1 | 2008 | 571 | 0.02 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Risk | 1 | 2016 | 5288 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Adaptation, Psychological | 1 | 2021 | 4996 | 0.02 | Why? |
| Burnout, Professional | 1 | 2018 | 2489 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Renal Dialysis | 1 | 2019 | 4358 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Triage | 1 | 2019 | 7151 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2016 | 7972 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Depression | 1 | 2021 | 14116 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.01 | Why? |
| Obesity | 1 | 2016 | 7388 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |